Literature DB >> 12515909

Evaluation of nitric oxide (NO) levels in hepatitis C virus (HCV) infection: relationship to schistosomiasis and liver cirrhosis among Egyptian patients.

Mahmoud Ismail Hassan1, Samar Kamal Kassim, Hebatalla Said Ali, El-Dieb Abd ElSattar Sayed, Ali Khalifa.   

Abstract

Nitric oxide (NO), a recently discovered free radical, is overproduced in liver cirrhosis. Hepatitis C virus (HCV) might increase NO levels via increased inducible NO synthase (iNOS). This work was carried out to study the effect of HCV-induced liver cirrhosis on NO levels among Egyptian patients. The study included 46 patients with liver cirrhosis, and 30 healthy individuals of matched age and sex. NO levels determined as the stable endproduct nitrate, showed a statistically significant increase among patients compared to the control group (P < 0.001). Furthermore, NO levels increased proportionally with the severity of liver cirrhosis as assessed by Child's classification (P < 0.05). Moreover, schistosomial infection enhanced NO levels in cirrhotic patients with HCV infection compared to non-bilharzial patients (P < 0.001). Polymerase chain reaction (PCR) and branched DNA assays were used for detection of HCV RNA positivity, and measurement of the virus load, respectively. Both showed a positive correlation with the NO levels (P < 0.001). At a nitrate cutoff value of 70 micromol/L, the sensitivity and specificity were 83.0% and 73.0%, respectively. Chi square analysis showed a significant correlation between ALT levels and both HCV RNA positivity by polymerase chain reaction (PCR) (P < 0.02), and virus load (P<0.05). Interestingly enough, there was a significant positive correlation between HCV RNA and schistosomal antibody titer as measured by hemaglutination inhibition assay (HAI) (P < 0.05). The data presented in this report indicated an association between NO levels and the development and progression of liver cirrhosis. Furthermore, the findings obtained from this study demonstrated that schistomiasis is an important risk factor involved in enhancement of NO levels and virus replication. The latter may aggravate liver cell injury and hence the development of cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515909      PMCID: PMC3851405          DOI: 10.1155/2002/647961

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  8 in total

1.  Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4.

Authors:  A Abdel Moneim; H A Suleiman; B Mahmoud; D Mabrouk; M Y Zaky; B Mahmoud
Journal:  Clin Exp Med       Date:  2020-02-19       Impact factor: 3.984

2.  Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: impact of bilharziasis and fibrosis stage.

Authors:  M F Derbala; S R Al Kaabi; N Z El Dweik; F Pasic; M T Butt; R Yakoob; A Al-Marri; A M Amer; N Morad; A Bener
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

3.  Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis?

Authors:  Waheed Abdelmonsef Mahmoud; Nadia Abdelaaty Abdelkader; Amal Mansor
Journal:  Indian J Gastroenterol       Date:  2013-11-29

4.  Nitric oxide levels in chronic liver disease patients with and without oesophageal varices.

Authors:  Assem M El-Sherif; Mohamed A Abou-Shady; Ashraf M Al-Bahrawy; Reda M Bakr; Abdel-Moneim M Hosny
Journal:  Hepatol Int       Date:  2008-04-22       Impact factor: 6.047

5.  Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.

Authors:  Onder Akkaya; Murat Kiyici; Yusuf Yilmaz; Engin Ulukaya; Omer Yerci
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

6.  Circulating viral core and E1 antigen levels as supplemental markers for HCV chronic hepatitis.

Authors:  Mostafa K El Awady; Yasmine S El Abd; Hussein A Shoeb; Ashraf A Tabll; Alaa El Din M S Hosny; Reem M El Shenawy; Khaled Atef; Noha G Bader El Din; Mahmoud M Bahgat
Journal:  Virol J       Date:  2006-09-01       Impact factor: 4.099

7.  Caffeic Acid Phenethyl Ester inhibit Hepatic Fibrosis by Nitric Oxide Synthase and Cystathionine Gamma-Lyase in Rats.

Authors:  Yan Shi; Li Guo; Lu Shi; Jinyang Yu; Min Song; Yana Li
Journal:  Med Sci Monit       Date:  2015-09-17

8.  Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure.

Authors:  Ana Carolina Urbaczek; Lívia Carolina de Abreu Ribeiro; Valdecir Farias Ximenes; Ana Afonso; Camila Tita Nogueira; Wesley Cardoso Generoso; Juliana Vieira Alberice; Martina Rudnicki; Renila Ferrer; Luiz Marcos da Fonseca; Paulo Inácio da Costa
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-09-09       Impact factor: 2.743

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.